UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
78.78 +0.40 (+0.51%) GOLD FUTURES
2,323.50 -0.70 (-0.03%) DOW
38,952.14 +67.88 (+0.17%) Bitcoin GBP
50,043.49 -757.39 (-1.49%)
Aclaris Therapeutics, Inc. (ACRS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:21PM EDT. Market open.
| Previous close | 1.3400 |
| Open | 1.2500 |
| Bid | 1.2300 x 500 |
| Ask | 1.2700 x 800 |
| Day's range | 1.2100 - 1.3475 |
| 52-week range | 0.5900 - 11.1200 |
| Volume | |
| Avg. volume | 1,013,900 |
| Market cap | 89.081M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23835, expectations were $-0.28. Aclaris Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
- Thomson Reuters StreetEvents
Q1 2024 Aclaris Therapeutics Inc Earnings Call
Q1 2024 Aclaris Therapeutics Inc Earnings Call
- GuruFocus.com
Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Exploring the robust financial positioning and strategic developments of Aclaris Therapeutics in the first quarter of 2024.
© 2024 Yahoo. All rights reserved.